SPDR® S&P Pharmaceuticals ETF (XPH US) stock market data APIs
42.7419
-0.37(-0.9%)
as of July 29, 2025
Try our APIs with
free plan!
SPDR® S&P Pharmaceuticals ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
42.7419
Open
42.3731
High
42.3731
Low
42.4583
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SPDR® S&P Pharmaceuticals ETF data using free add-ons & libraries
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SPDR® S&P Pharmaceuticals ETF News
New
Novartis CEO: Tariffs are an overhang on the pharmaceutical sector
[Young female scientist working in laboratory] Solskin Novartis (NYSE:NVS [https://seekingalpha.com/symbol/NVS]) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate...
Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again
The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV [https://seekingalpha.com/symbol/XLV]) experienced an increase in June, moving from 1.90% in May to 1.96%, indicating ...
Big pharma's multiple looming patent cliffs: What to know
The pharmaceutical industry is staring down a major patent cliff, with key drugs from Merck (MRK), Bristol Myers Squibb (BMY), and Johnson & Johnson (JNJ) set to lose exclusivity by 2030. Yahoo Finan...
Top rated and bottom rated stocks according to 3 key drivers of performance – UBS
[Top Prospects Most Profitable Stock Market Best Investments 3d Illustration] iQoncept/iStock via Getty Images UBS analysts listed top and bottom-ranked stocks based on a key set of drivers for equit...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
